Riverbridge Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-3,981
| Closed | -$231K | – | 205 |
|
2023
Q3 | $231K | Hold |
3,981
| – | – | ﹤0.01% | 183 |
|
2023
Q2 | $255K | Hold |
3,981
| – | – | ﹤0.01% | 175 |
|
2023
Q1 | $276K | Hold |
3,981
| – | – | ﹤0.01% | 171 |
|
2022
Q4 | $286K | Hold |
3,981
| – | – | ﹤0.01% | 175 |
|
2022
Q3 | $283K | Hold |
3,981
| – | – | ﹤0.01% | 174 |
|
2022
Q2 | $307K | Hold |
3,981
| – | – | ﹤0.01% | 174 |
|
2022
Q1 | $291K | Sell |
3,981
-1,444
| -27% | -$106K | ﹤0.01% | 149 |
|
2021
Q4 | $338K | Hold |
5,425
| – | – | ﹤0.01% | 152 |
|
2021
Q3 | $321K | Hold |
5,425
| – | – | ﹤0.01% | 144 |
|
2021
Q2 | $362K | Sell |
5,425
-21
| -0.4% | -$1.4K | ﹤0.01% | 143 |
|
2021
Q1 | $344K | Buy |
5,446
+21
| +0.4% | +$1.33K | ﹤0.01% | 141 |
|
2020
Q4 | $337K | Sell |
5,425
-400
| -7% | -$24.8K | ﹤0.01% | 137 |
|
2020
Q3 | $351K | Hold |
5,825
| – | – | ﹤0.01% | 135 |
|
2020
Q2 | $343K | Hold |
5,825
| – | – | 0.01% | 128 |
|
2020
Q1 | $325K | Hold |
5,825
| – | – | 0.01% | 121 |
|
2019
Q4 | $374K | Hold |
5,825
| – | – | 0.01% | 124 |
|
2019
Q3 | $295K | Hold |
5,825
| – | – | 0.01% | 125 |
|
2019
Q2 | $264K | Hold |
5,825
| – | – | 0.01% | 128 |
|
2019
Q1 | $278K | Hold |
5,825
| – | – | 0.01% | 124 |
|
2018
Q4 | $303K | Hold |
5,825
| – | – | 0.01% | 124 |
|
2018
Q3 | $362K | Hold |
5,825
| – | – | 0.01% | 120 |
|
2018
Q2 | $322K | Hold |
5,825
| – | – | 0.01% | 116 |
|
2018
Q1 | $368K | Hold |
5,825
| – | – | 0.01% | 119 |
|
2017
Q4 | $357K | Buy |
+5,825
| New | +$357K | 0.01% | 124 |
|